0001415889-24-008106.txt : 20240315
0001415889-24-008106.hdr.sgml : 20240315
20240315161509
ACCESSION NUMBER: 0001415889-24-008106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwab Andrew J.
CENTRAL INDEX KEY: 0001598549
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55136
FILM NUMBER: 24754922
MAIL ADDRESS:
STREET 1: C/O 5AM VENTURES
STREET 2: 501 2ND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Skye Bioscience, Inc.
CENTRAL INDEX KEY: 0001516551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450692882
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11250 EL CAMINO REAL, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 410-0266
MAIL ADDRESS:
STREET 1: 11250 EL CAMINO REAL, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Emerald Bioscience, Inc.
DATE OF NAME CHANGE: 20190325
FORMER COMPANY:
FORMER CONFORMED NAME: Nemus Bioscience, Inc.
DATE OF NAME CHANGE: 20141030
FORMER COMPANY:
FORMER CONFORMED NAME: LOAD GUARD LOGISTICS, INC.
DATE OF NAME CHANGE: 20121107
4
1
form4-03152024_040302.xml
X0508
4
2024-03-13
0001516551
Skye Bioscience, Inc.
SKYE
0001598549
Schwab Andrew J.
C/O 5AM VENTURE MANAGEMENT, LLC
501 2ND STREET, SUITE 350
SAN FRANCISCO
CA
94107
true
false
true
false
0
Common Stock
2024-03-13
4
A
0
450000
10
A
8393520
I
By 5AM Ventures VII, L.P.
Common Stock
1718189
I
By 5AM Ventures II, L.P.
Common Stock
67796
I
By 5AM Co-Investors II, L.P.
The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ Andrew J. Schwab
2024-03-15